Back to search

Article

Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning Study

2020-04-15

Abstract excerpt

<h4>Objective: </h4> About a third of schizophrenia patients are treatment-resistant to antipsychotic therapy. No studies established the fingerprints or pathway-phenotypes of treatment-resistant schizophrenia. The present study aimed to delineate the pathway-phenotypes of non-responders (NRTT) and partial responders (PRTT) to treatment using machine learning. <h4>Methods:</h4> We recruited 115 schizophrenia patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43e80909-1b1f-58f4-a04f-d670629b942a
DOI
10.20944/preprints202004.0231.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning StudyDOI 10.20944/preprints202004.0231.v1
In Schizophrenia, Depression and Anxiety Symptoms Are Driven by Immune-Inflammatory Pathways.Semantic proximity
The novel pathway phenotype “major neurocognitive psychosis” is validated as a distinct class through the analysis of immune-linked neurotoxicity biomarkers and neurocognitive deficitsSemantic proximity
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit SchizophreniaSemantic proximity
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia.Semantic proximity
Refining Schizophrenia Risk Assessment: Machine Learning Delineates a Brain Signature of Cognitive Basic SymptomsSemantic proximity
Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.Semantic proximity
Revealing the Oxidative Stress-Related Molecular Characteristics and Potential Therapeutic Targets of Schizophrenia through Integrated Gene Expression Data AnalysisSemantic proximity
A new schizophrenia model: immune activation is associated with induction of the tryptophan catabolite pathway and increased eotaxin levels which together determine memory impairments and schizophrenia symptom dimensionsSemantic proximity
Monocytic Subsets and Their Signature Genes Differentially Impact Cortex and Cognition in First-Episode SchizophreniaSemantic proximity
Cerebrospinal fluid proteomics reveals synaptic and immune dysregulation in treatment-resistant schizophreniaSemantic proximity
Machine learning reduced gene/non-coding RNA features that classify Schizophrenia patients accurately and highlight insightful gene clustersSemantic proximity
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.Semantic proximity
Select a neighboring publication to make it the new centre.